Mastectomy Clinical Trials

Clinical trials related to Mastectomy Procedure

Efficacy of Erector Spinae Plane (ESP) Blocks in Free Flap-Based Breast Reconstruction: A Randomized Controlled Study

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY

This study is a prospective randomized controlled trial to assess the efficacy of erector spinae plane (ESP) blocks in patients undergoing autologous free flap breast reconstruction. Currently, patients undergoing this procedure remain in the hospital initially for flap monitoring until discharge criteria is met, when pain is adequately controlled and patient is able to ambulate independently. Prolonged hospital stays can occur due to persistent pain, typically abdominal pain as breasts are insensate following mastectomy. Persistent pain at abdominal incision can increase opioid requirements, impede ambulation trials, and delay discharge. This study aims to utilize ESP blocks to help augment pain control in patients undergoing autologous free flap breast reconstruction. The ESP block is a safe regional block that is already commonly utilized by multiple surgical specialties, such as general surgery, obstetrics and gynecology, cardiothoracic surgery, neurosurgery, and orthopedic surgery. The ESP block is an ultrasound-guided regional anesthesia technique where a local anesthetic is injected into the fascial plane between the erector spinae muscles and the thoracic vertebrae's transverse processes. This injection spreads longitudinally, blocking the spinal nerves and providing multi-dermatomal pain relief to the anterior, posterior, and lateral chest and abdominal walls, making it useful for surgeries and managing chronic pain. Patients in this study will be randomized into one of two groups, ESP block or No ESP (NESP) block group. The investigators will not be blinding patients to their study arm assignment, as this would require injecting placebo which the investigators believe would be an unnecessary risk to patient. Additionally, it was determined that it would not be feasible to blind patients as the ESP block participants would be numb in their abdomen and patients would immediately know whether or not they received the block. Participants will be informed of their study arm assignment on the day of surgery prior to proceeding to the operating room. Patients will then be asked to fill out a twice daily survey on pain and ambulation trials. Inpatient data on pain medication administration and time to discharge will be collected through chart review. This study aims to investigate the efficacy of ESP blocks to improve management of pain at abdominal incision, decrease inpatient opioid consumption, decrease time to ambulation, and decrease length of stay.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Diagnosis of breast cancer

• Undergoing abdominally based autologous free flap breast reconstruction

• Age 18-75

• BMI \<40

• Must be able to consent for themself

Locations
United States
Virginia
Roanoke Memorial Hospital
RECRUITING
Roanoke
Contact Information
Primary
Joowon Choi, MD
jmchoi@carilionclinic.org
540-682-6695
Time Frame
Start Date: 2026-10-01
Estimated Completion Date: 2028-06-30
Participants
Target number of participants: 60
Treatments
Experimental: ESP Block
Patients will receive ESP block, as well as standard of care/pain medications
No_intervention: No Block
Patients will not receive ESP block, but only standard of care/pain medications
Related Therapeutic Areas
Sponsors
Leads: Carilion Clinic

This content was sourced from clinicaltrials.gov